United Kingdom · Question · Written question
UIN 2751
Obesity: Health Services
Original
Introduced
19 May 2026
Last action
2 June 2026 · Answer
Status
Answered
Sponsors
—
Subjects
Discovery layer
Source updated
2 June 2026
Summary
To ask the Secretary of State for Health and Social Care, what steps his Department is taking to ensure that NICE guidance on GLP-1 medications for obesity is implemented consistently across Integrated Care Boards; and if he will review the methodology us
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
19 May 2026
Written question
To ask the Secretary of State for Health and Social Care, what steps his Department is taking to ensure that NICE guidance on GLP-1 medications for obesity is implemented consistently across Integrated Care Boards; and if he will review the methodology us
Source: Commons
2 June 2026
Answer
Integrated care boards (ICBs) are legally required to make funding available for medicines recommended by the National Institute for Health and Care Excellence (NICE) in line with NICE guidance and the NICE Funding Variation for tirzepatide. NHS England i...
Source: Written answer
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
- · Department of Health and Social Care · Answering body
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://questions-statements.parliament.uk/written-questions/detail/2026-05-19/2751
- Open data entity: https://questions-statements-api.parliament.uk/api/writtenquestions/questions/1907293
- uk · wq-1907293 · source updated 2 June 2026